50.34USD-1.31%Mkt Cap: 12.69B USDP/E: 16.72Last update: 2026-06-01
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatme…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap12.69B USD
Enterprise Value12.08B USD
Revenue (TTM)2.38B USD
Gross Profit2.24B USD
Net Income (TTM)782.57M USD
Revenue/Share8.915 USD
Last Price50.34 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.1K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS30161Q1040
Valuation
P/E (Trailing)16.72
P/E (Forward)12.47
PEG2.56
EV/EBITDA12.25
EV/Revenue5.09
P/S5.34
P/B6.62
EPS (TTM)3.02
EPS (Forward)4.05
52W Range
33.7686% of range52.96
52W High52.96 USD
52W Low33.76 USD
Profitability
Gross Margin96.39%
Oper. Margin41.15%
EBITDA Margin41.50%
Profit Margin33.73%
ROE36.21%
ROA27.51%
Growth
Revenue Growth10.00%
Earnings Growth43.60%
Cash Flow & Leverage
Operating CF884.27M USD
CapEx (TTM)39.93M USD
FCF Margin26.48%
FCF Yield4.96%
Net Debt-607.67M USD
Net Debt/EBITDA-0.62
Balance Sheet
Debt/Equity0.08
Current Ratio3.26
Quick Ratio3.01
Book Value/Sh7.630 USD
Cash/Share3.092 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)49.65 USD
Target Range40.00 USD – 62.00 USD
# Analysts17
Ownership
Shares Out.251.36M
Float204.52M
Insiders1.81%
Institutions107.53%
Short Interest
Short Ratio10.6d
Short % Float16.38%
Short % Out.12.05%
Shares Short30.28M
Short (prev mo.)28.31M
Technical
SMA 5045.70 (+10.1%)
SMA 20042.45 (+18.6%)
Beta0.39
S&P 52W Chg27.94%
Avg Vol (30d)2.55M
Avg Vol (10d)2.35M
Technical Indicators
RSI (14)60.5
MACD1.5314
MACD Signal1.4704
MACD Hist.+0.0610
BB Upper53.87 USD
BB Middle48.96 USD
BB Lower44.05 USD
BB Width20.06%
ATR (14)1.538 USD
Vol Ratio (20d)0.34x